Eye-opening care. Life-changing results. Far-reaching implications.
At Chu Vision, we help patients move forward with confidence by providing clear, concise information upfront and kind, considerate care throughout. We are also committed to advancing the field of eye care. Learn more about how we have taken a leadership role within our professional community—locally and globally—to help bring leading-edge technologies to market.
Current Clinical Trials
+ Vision Correction
Do you rely on your glasses or contacts to see clearly? Carl Zeiss Meditec and Chu Vision Institute are conducting a research study on a laser to perform laser vision correction (i.e., LASIK) to correct nearsightedness and farsightedness with and without astigmatism. This laser has not been used in the U.S. and is considered investigational by the FDA.
You may qualify for this research study if:
- You have nearsightedness or farsightedness with or without astigmatism
- You are at least 18 years of age
- You have had no previous eye surgery, significant trauma or infections in either of your eyes
- You have a pair of glasses that are at least one year old
- You are in good health
If you qualify for this research study, LASIK will be performed on both of your eyes at no cost to you.
If you have been diagnosed with mild to moderate open-angle glaucoma and are currently taking up to three anti-glaucoma medications, you may be eligible to participate in a research study.
Dr. Ralph Chu is currently participating in a research study to evaluate a product called Travoprost Intraocular Implant for patients with glaucoma, designed to reduce eye pressure by delivering glaucoma medications slowly into your eye over time.
For more information or to set up an appointment, please call 952-234-8295 or email [email protected]
To learn more visit www.GlaukosClinicalTrials.com.
Nic Jacobs, VP Clinical Research and Regulatory
Committed to Advancing the Field of Ophthalmology Through Research - Watch to learn more as we have participated in over 90 research studies!